Usefulness of low-density lipoprotein particle size measurement in cardiovascular disease prevention

Clinical Cardiology

Volumn 28, Issue 11, 2005, Pages 534-537

  Brook, Robert D ^a,b   Kansal, Mayank ^a   Bard, Robert L ^a   Eagle, Kim ^a   Rubenfire, Melvyn ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

Cardiovascular disease; Lipids; Risk factors; Screening

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GEL ELECTROPHORESIS; HIGH RISK PATIENT; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PARTICLE SIZE; RISK ASSESSMENT; SCORING SYSTEM;

EID: 27744473300     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960281109     Document Type: Article

References (21)

1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTER-HEART study): Case-control study. Lancet 2004;364:952-962
2. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW: Major risk factors as antecendents of fatal and nonfatal coronary heart disease events. J Am Med Assoc 2003;290:891-897
3. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 1999;34:1348-1359
4. Greenland P, Smith SC, Grundy SM: Improving coronary heart disease risk assessment in asymptomatic people. Role of traditional risk factors and non-invasive cardiovascular tests. Circulation 2001;104:1863-1867
5. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL: Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004;109(suppl IV):IV6-IV19
6. Bard RL, Kalsi H, Rubenfire M, Wakefield T, Fex B, Rajagopalan S, Brook RD: Effect of carotid atherosclerosis screening on risk stratification during primary cardiovascular disease prevention. Am J Cardiol 2004;93:1030-1032
7. Bard RL, Rubenfire M, Eagle K, Clarke NS, Brook RD: Utility of C-reactive protein measurement in risk stratification during primary cardiovascular disease prevention. Am J Cardiol 2005;95:1378-1379
8. http://www.liposcience.com/ (accessed April 4, 2005).
9. http://www.atherotech.com/ (accessed April 4, 2005).
10. http://www.berkeleyheartlab.com/ (accessed April 4, 2005).
11. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment on High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486-2509
12. Lamarche B, Tchernof A, Moorjani S, Prud'homme D, Nadeau A, Tremblay A, Lupien PJ, Bouchard C, Despres JP: Small, dense LDL particles as a predictor of the risk of ischemic heart disease in men: Prospective results from the Quebec Cardiovascular Study. Circulation 1997;95:69-75
13. St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Bernard PM. Despres JP. Lamarche B: Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 2001;104:2295-2299
14. St-Pierre AC, Cantin B, Dagenais GR, Mauriège P, Bernard PM, Després JP, Lamarche B: Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men. 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 2005;25:553-559
15. Campos H, Moyé LA, Glasser SP, Stampfer MJ, Sacks FM: Low-density lipoprotein size, pravastatin treatment, and coronary events. J Am Med Assoc 2001;286:1468-1474
16. Rajman I, Eacho PI, Chowienczyk PJ. Ritter JM: LDL particle size: An important drug target? Br J Clin Pharmacol 1999;48:125-133
17. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH: A prospective study of TG level, LDL particle diameter, and risk of myocardial infarction. J Am Med Assoc 1996;276:882-888
18. Gardner CD, Fortmann SP, Krauss RM: Association of small LDL particles with the incidence of CAD in men and women. J Am Med Assoc 1996;276:875-881
19. Otvos JD, Jeyarajah EJ, Cromwell WC: Measurement issues related to lipoprotein heterogeneity. Am J Cardiol 2002;90(suppl):22i-29i
20. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. J Am Med Assoc 2002;287:356-359
21. Ford ES, Mokdad AH, Giles WH: Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults. Findings from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2003;107:2185-2189